Alx Oncology
NASDAQ: ALXOUnicorn · $3BFounded 2015 · Incorporated in Delaware · 64 employees on LinkedIn · 6 known investors
Find your way into Alx Oncology
13 people in our graph share verified history with the Alx Oncology team — schools, employers, funds. One of them is your warm intro.
Aaron Roystonunlockedknows Corey Goodman · together at venBio Partners
×11knows the team · via venBio Partners
ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.
Founders & leadership
Alx Oncology was founded in 2015 by Corey Goodman.
CG
Investors · 6
Valuation · disclosed
Disclosed events$3Bvaluation at IPODec 2020 · $76.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 2
by search overlap
Exelixis21 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Solu16 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Companies competing with Alx Oncology for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Alx Oncology do?
- ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.
- Who founded Alx Oncology?
- Alx Oncology was founded by Corey Goodman in 2015.
- Who are Alx Oncology's investors?
- Alx Oncology's investors include Lightstone Ventures, age1, Foresite Capital, venBio Partners, Logos, Vivo Capital.